HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of continuous epitopes of the envelope glycoprotein of dengue type 2 virus.

Abstract
We reacted 490 hexapeptides homologous to the amino acid sequence of the dengue 2 (DEN-2) virus envelope glycoprotein with antisera from 7 patients with primary DEN-2 virus infections to identify the continuous epitopes recognized by human IgG. There were 124 peptides in 25 clusters (domains) that bound 2 or more antisera. Twenty-two peptides in 7 domains bound all 7 convalescent DEN-2 virus antisera tested, and thus appeared to represent immunodominant epitopes. The evidence that these domains represents continuous epitopes of the envelope glycoprotein is that peptide representing each domain bound multiple sera, peptide reactivity was highly ordered along the amino acid sequence, and in almost all cases, domains were regions of predicted hydrophilicity. Heterologous flavivirus antisera also exhibited binding to the majority of peptides reactive with anti-DEN-2 virus sera, though 4 candidate DEN-2 specific epitopes were identified along with an immunodominant epitope common to dengue, Japanese encephalitis and West Nile viruses. Synthetic peptides representing these epitopes may prove to be useful for a variety of purposes.
AuthorsB L Innis, V Thirawuth, C Hemachudha
JournalThe American journal of tropical medicine and hygiene (Am J Trop Med Hyg) Vol. 40 Issue 6 Pg. 676-87 (Jun 1989) ISSN: 0002-9637 [Print] United States
PMID2472749 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Amino Acids
  • Epitopes
  • Membrane Glycoproteins
Topics
  • Amino Acids (analysis)
  • Dengue Virus (immunology)
  • Epitopes (analysis)
  • Humans
  • Immunoassay
  • Membrane Glycoproteins (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: